An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.

Lin, Mao; Alnaggar, Mohammed; Liang, Shuzhen; Wang, Xiaohua; Liang, Yinqing; Zhang, Mingjie; Chen, Jibing; Niu, Lizhi; Xu, Kecheng

Lin, Mao; Alnaggar, Mohammed; Liang, Shuzhen; Wang, Xiaohua; Liang, Yinqing; Zhang, Mingjie; Chen, Jibing; Niu, Lizhi; Xu, Kecheng.

Afiliación

Lin M; Fuda Cancer Hospital, School of Medicine, Jinan University, Guangzhou, China.
Alnaggar M; Fuda Cancer Institute, Guangzhou, China.
Liang S; Fuda Cancer Hospital, School of Medicine, Jinan University, Guangzhou, China.
Wang X; Fuda Cancer Hospital, School of Medicine, Jinan University, Guangzhou, China.
Liang Y; Fuda Cancer Hospital, School of Medicine, Jinan University, Guangzhou, China.
Zhang M; Fuda Cancer Hospital, School of Medicine, Jinan University, Guangzhou, China.
Chen J; Hank Bioengineering Co., Ltd, Shenzhen, China.
Niu L; Fuda Cancer Hospital, School of Medicine, Jinan University, Guangzhou, China.
Xu K; Fuda Cancer Institute, Guangzhou, China.

Oncotarget ; 8(60): 101795-101807, 2017 Nov 24.

Article en En | MEDLINE | ID: mdl-29254205

Palabras clave

allogeneic natural killer cell; clinical efficacy; irreversible electroporation; pancreatic cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google